bioMérieux: 1988 – 2007

Published : 22.06.2007
#Success Story
  • 19 years of ownership
  • Creation of a global player in in-vitro diagnostics; world leader in clinical and industrial microbiology
  • 330 margin improvement points over the 2003-2007 period
  • IPO in 2004
  • Investment multiple of 4.4x
  • Amount invested by Wendel: €106 million
40 years

40 years of sustainable growth

For more than 40 years, Wendel has been a pioneer in the private equity sector. Over the decades, the Group’s teams have made bold investment choices at strategic times. These successes are illustrated by the creation of world leaders specializing in various sectors.